BackSmith & Nephew plc Overview
Smith & Nephew plc - ADR

Smith & Nephew plc Target Price

Analysts' average 12-month price target for Smith & Nephew plc is $31.

Get informed when a big investor buys or sells

+ Follow

Share Price

$28.87

Average Target Price

$30.937.1% upside

2 analysts in the last 4 months

High: $31.85 | Low: $30

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-11Bernstein$31.8510.3% upsideOpen
2026-05-11Canaccord Genuity$303.9% upsideOpen
2026-04-24Canaccord GenuityCaitlin Cronin$3210.8% upsideOpen
2025-10-14Bernstein$37.529.9% upsideOpen
2025-08-18Canaccord GenuityCaitlin Cronin$3624.7% upsideOpen
2024-11-04Canaccord GenuityKyle Rose$276.5% downsideOpen

Smith & Nephew plc (SNN) FAQ

Smith & Nephew plc (SNN) currently reports a target price of $31. Use the charts on this page to explore Smith & Nephew plc's target price history and peer comparisons.

Analysts' average 12-month price target for Smith & Nephew plc is $31, about 7.1% upside from the current share price of $28.87. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $31, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Smith & Nephew plc, and consider following SNN for alerts when major investors trade the stock.

Smith & Nephew plc is classified in the Healthcare sector. On target price, it currently shows $31. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SNN with unrelated industries.